Sitagliptin SUN Eiropas Savienība - latviešu - EMA (European Medicines Agency)

sitagliptin sun

sun pharmaceutical industries europe b.v. - sitagliptin fumarate - cukura diabēts, 2. tips - cukura diabēts - for adult patients with type 2 diabetes mellitus, sitagliptin sun is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. a thiazolidinedione) when use of a pparγ agonist is appropriate and when diet and exercise plus the pparγ agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a pparγ agonist and metformin when use of a pparγ agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin sun is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.

Jamesi 50 mg/850 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

jamesi 50 mg/850 mg apvalkotās tabletes

zentiva, k.s., czech republic - sitagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/850 mg

Jamesi 50 mg/1000 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

jamesi 50 mg/1000 mg apvalkotās tabletes

zentiva, k.s., czech republic - sitagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/1000 mg

Sitagliptin Grindeks 25 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

sitagliptin grindeks 25 mg apvalkotās tabletes

grindeks, as, latvia - sitagliptīns - apvalkotā tablete - 25 mg

Sitagliptin/Metformin Grindeks 50 mg/850 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

sitagliptin/metformin grindeks 50 mg/850 mg apvalkotās tabletes

grindeks, as, latvia - sitagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/850 mg

Sitagliptin/Metformin Grindeks 50 mg/1000 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

sitagliptin/metformin grindeks 50 mg/1000 mg apvalkotās tabletes

grindeks, as, latvia - sitagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/1000 mg

Sitagliptin Grindeks 50 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

sitagliptin grindeks 50 mg apvalkotās tabletes

grindeks, as, latvia - sitagliptīns - apvalkotā tablete - 50 mg

Sitagliptin Grindeks 100 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

sitagliptin grindeks 100 mg apvalkotās tabletes

grindeks, as, latvia - sitagliptīns - apvalkotā tablete - 100 mg

Sitagliptin/Metformin hydrochloride Teva 50 mg/850 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

sitagliptin/metformin hydrochloride teva 50 mg/850 mg apvalkotās tabletes

teva gmbh, germany - sitagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/850 mg

Sitagliptin/Metformin hydrochloride Teva 50 mg/1000 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

sitagliptin/metformin hydrochloride teva 50 mg/1000 mg apvalkotās tabletes

teva gmbh, germany - sitagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/1000 mg